ar
Feedback
๐—”๐—ฅ๐—ข๐—ก ๐—ฆ๐—ง๐—จ๐——๐—ฌ

๐—”๐—ฅ๐—ข๐—ก ๐—ฆ๐—ง๐—จ๐——๐—ฌ

ุงู„ุฐู‡ุงุจ ุฅู„ู‰ ุงู„ู‚ู†ุงุฉ ุนู„ู‰ Telegram

ุจุณู… ุงู„ู„ู‡ ุงู„ุฑุญู…ู† ุงู„ุฑุญูŠู… ุงู„ู„ู‡ู… ุตู„ ุนู„ู‰ ู…ุญู…ุฏ ูˆุขู„ ู…ุญู…ุฏ ู…ุญุชูˆู‰ ุงู„ู‚ู†ุงุฉ: ุดุฑูˆุญุงุช ุตูŠุฏู„ุฉ ุนุถูˆูŠุฉ ู…ุฑุญู„ุฉ ุซุงู†ูŠุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุซุงู„ุซุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุฑุงุจุนุฉ ูƒูˆุฑุณ ุงูˆู„ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุฑุงุจุนุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ุนู„ุงุฌูŠุงุช ู…ุฑุญู„ุฉ ุฎุงู…ุณุฉ ู„ู„ุชูˆุงุตู„: @AronX2bot

ุฅุธู‡ุงุฑ ุงู„ู…ุฒูŠุฏ

๐Ÿ“ˆ ู†ุธุฑุฉ ุชุญู„ูŠู„ูŠุฉ ุนู„ู‰ ู‚ู†ุงุฉ ุชูŠู„ูŠุฌุฑุงู… ๐—”๐—ฅ๐—ข๐—ก ๐—ฆ๐—ง๐—จ๐——๐—ฌ

ุชูุนุฏ ู‚ู†ุงุฉ ๐—”๐—ฅ๐—ข๐—ก ๐—ฆ๐—ง๐—จ๐——๐—ฌ (@aronstudy) ููŠ ุงู„ู‚ุทุงุน ุงู„ู„ุบูˆูŠ ุงู„ุนุฑุจูŠุฉ ู„ุงุนุจุงู‹ ู†ุดุทุงู‹. ูŠุถู… ุงู„ู…ุฌุชู…ุน ุญุงู„ูŠุงู‹ 13 339 ู…ุดุชุฑูƒุงู‹ุŒ ู…ุญุชู„ุงู‹ ุงู„ู…ุฑุชุจุฉ 1 928 ููŠ ูุฆุฉ ุงู„ุทุจ ูˆุงู„ู…ุฑุชุจุฉ 5 694 ููŠ ู…ู†ุทู‚ุฉ ุงู„ู…ู…ู„ูƒุฉ ุงู„ุนุฑุจูŠุฉ ุงู„ุณุนูˆุฏูŠุฉ.

๐Ÿ“Š ู…ุคุดุฑุงุช ุงู„ุฌู…ู‡ูˆุฑ ูˆุงู„ุญุฑุงูƒ

ู…ู†ุฐ ุชุฃุณูŠุณู‡ ููŠ ะฝะตะฒั–ะดะพะผะพุŒ ุญู‚ู‚ ุงู„ู…ุดุฑูˆุน ู†ู…ูˆุงู‹ ุณุฑูŠุนุงู‹ ูˆุฌู…ุน 13 339 ู…ุดุชุฑูƒุงู‹.

ุจุญุณุจ ุขุฎุฑ ุงู„ุจูŠุงู†ุงุช ุจุชุงุฑูŠุฎ 28 ูŠูˆู†ูŠูˆ, 2026ุŒ ุชุญุงูุธ ุงู„ู‚ู†ุงุฉ ุนู„ู‰ ู†ุดุงุท ู…ุณุชู‚ุฑ. ุฎู„ุงู„ ุขุฎุฑ 30 ูŠูˆู…ุงู‹ ุชุบูŠู‘ุฑ ุนุฏุฏ ุงู„ุฃุนุถุงุก ุจู…ู‚ุฏุงุฑ 196ุŒ ูˆููŠ ุขุฎุฑ 24 ุณุงุนุฉ ุจู…ู‚ุฏุงุฑ -18ุŒ ู…ุน ุจู‚ุงุก ุงู„ูˆุตูˆู„ ุงู„ุนุงู… ู…ุฑุชูุนุงู‹.

  • ุญุงู„ุฉ ุงู„ุชุญู‚ู‚: ุบูŠุฑ ู…ูˆุซู‘ู‚ุฉ
  • ู…ุนุฏู„ ุงู„ุชูุงุนู„ (ER): ูŠุจู„ุบ ู…ุชูˆุณุท ุชูุงุนู„ ุงู„ุฌู…ู‡ูˆุฑ 27.91โ€Ž%. ูˆุฎู„ุงู„ ุฃูˆู„ 24 ุณุงุนุฉ ู…ู† ุงู„ู†ุดุฑ ูŠุญุตุฏ ุงู„ู…ุญุชูˆู‰ ุนุงุฏุฉู‹ 9.87โ€Ž% ู…ู† ุฑุฏูˆุฏ ุงู„ูุนู„ ู†ุณุจุฉู‹ ุฅู„ู‰ ุฅุฌู…ุงู„ูŠ ุงู„ู…ุดุชุฑูƒูŠู†.
  • ูˆุตูˆู„ ุงู„ู…ู†ุดูˆุฑุงุช: ูŠุญุตู„ ูƒู„ ู…ู†ุดูˆุฑ ุนู„ู‰ ู…ุชูˆุณุท 3 727 ู…ุดุงู‡ุฏุฉ. ูˆุฎู„ุงู„ ุงู„ูŠูˆู… ุงู„ุฃูˆู„ ูŠุฌู…ุน ุนุงุฏุฉู‹ 1 318 ู…ุดุงู‡ุฏุฉ.
  • ุงู„ุชูุงุนู„ุงุช ูˆุงู„ุงุณุชุฌุงุจุฉ: ูŠุชูุงุนู„ ุงู„ุฌู…ู‡ูˆุฑ ุจุงู†ุชุธุงู…ุ› ู…ุชูˆุณุท ุงู„ุชูุงุนู„ุงุช ู„ูƒู„ ู…ู†ุดูˆุฑ ูŠุจู„ุบ 36.
  • ุงู„ุงู‡ุชู…ุงู…ุงุช ุงู„ู…ูˆุถูˆุนูŠุฉ: ูŠุฑูƒุฒ ุงู„ู…ุญุชูˆู‰ ุนู„ู‰ ู…ูˆุงุถูŠุน ุฑุฆูŠุณูŠุฉ ู…ุซู„ ู…ูŽุงุฏูŽู‘ุฉ, ุทูŽุงู„ูุจ, ุงูุณุชูุจููŠูŽุงู†, ุณูŽู„ูŽุงู…, ุฑูุณูŽุงู„ูŽุฉ.

๐Ÿ“ ุงู„ูˆุตู ูˆุณูŠุงุณุฉ ุงู„ู…ุญุชูˆู‰

ูŠุตู ุงู„ู…ุคู„ู ุงู„ู‚ู†ุงุฉ ุจุฃู†ู‡ุง ู…ุณุงุญุฉ ู„ู„ุชุนุจูŠุฑ ุนู† ุงู„ุขุฑุงุก ุงู„ุฐุงุชูŠุฉ:
โ€œุจุณู… ุงู„ู„ู‡ ุงู„ุฑุญู…ู† ุงู„ุฑุญูŠู… ุงู„ู„ู‡ู… ุตู„ ุนู„ู‰ ู…ุญู…ุฏ ูˆุขู„ ู…ุญู…ุฏ ู…ุญุชูˆู‰ ุงู„ู‚ู†ุงุฉ: ุดุฑูˆุญุงุช ุตูŠุฏู„ุฉ ุนุถูˆูŠุฉ ู…ุฑุญู„ุฉ ุซุงู†ูŠุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุซุงู„ุซุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุฑุงุจุนุฉ ูƒูˆุฑุณ ุงูˆู„ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุฑุงุจุนุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ุนู„ุงุฌูŠุงุช ู…ุฑุญู„ุฉ ุฎุงู…ุณุฉ ู„ู„ุชูˆุงุตู„: @AronX2botโ€

ุจูุถู„ ูˆุชูŠุฑุฉ ุงู„ุชุญุฏูŠุซ ุงู„ู…ุฑุชูุนุฉ (ุฃุญุฏุซ ุงู„ุจูŠุงู†ุงุช ุจุชุงุฑูŠุฎ 29 ูŠูˆู†ูŠูˆ, 2026) ุชุญุงูุธ ุงู„ู‚ู†ุงุฉ ุนู„ู‰ ุญุฏุงุซุชู‡ุง ูˆู…ุณุชูˆู‰ ูˆุตูˆู„ ู…ุฑุชูุน. ูˆุชูุธู‡ุฑ ุงู„ุชุญู„ูŠู„ุงุช ุชูุงุนู„ุงู‹ ู†ุดุทุงู‹ ู…ู† ุงู„ุฌู…ู‡ูˆุฑุŒ ู…ุง ูŠุฌุนู„ู‡ุง ู†ู‚ุทุฉ ุชุฃุซูŠุฑ ู…ู‡ู…ุฉ ุถู…ู† ูุฆุฉ ุงู„ุทุจ.

13 339
ุงู„ู…ุดุชุฑูƒูˆู†
-1824 ุณุงุนุงุช
+2847 ุฃูŠุงู…
+19630 ุฃูŠุงู…
ุฃุฑุดูŠู ุงู„ู…ุดุงุฑูƒุงุช
ู…ุฑุญุจุง ุงู†ูŠ ุทุงู„ุจุฉ ุตูŠุฏู„ุฉ ุฌุงู…ุนู‡ ุงู„ู…ุดุฑู‚ ุนู†ุฏูŠ ุจุญุซ ูŠุฎุต ุจุฎุงุฎุงุช ุงู„ุฑุจูˆ ูˆ COPD ู…ู…ูƒู† ุชู…ู„ูˆู† ุงู„ุงุณุชุจูŠุงู† ูˆ ุงู‡ู…ุดูŠ ุฑู‚ู… collaborator code :3 ูˆ ุดูƒุฑุงู‹ https://forms.gle/hFujpBaFvBNf3kNF6

An intramuscular agent, is approved for second line therapy of postmenopausal patients with hormone receptor-positive breast cancer either alone or in combination with targeted therapy? A) Tamoxifen B) Raloxifene C) Toremifene D) pertuzumab E) Fulvestrant ุจู…ุญุงุถุฑุฉ ุงู„ breast cancer ูู‚ุท ุฏูˆุงุก ูˆุงุญุฏ ู…ุฐูƒูˆุฑ ุงู†ู‡ ู†ู†ุทูŠู‡ im ูŠุนู†ูŠ ุจุฏูˆู† ู…ุง ุชูƒู…ู„ ุงู„ุณุคุงู„ ุชุฎุชุงุฑ ูˆุงู†ุช ู…ุบู…ุถ ูˆูƒู„ุงู… ุงู„ุณุคุงู„ ู†ุตุง ู…ู† ุงู„ู…ู„ุฒู…ุฉ ู…ุงูƒูˆ ู…ุนู„ูˆู…ุฉ ู…ู…ูŠุฒุฉ ู…ุฌุฑุฏ ู…ุนู„ูˆู…ุฉ ุฏุฑุฎูŠุฉ ูˆุฒุงุฑูŠ 25 ุฏูˆุฑ 1 #Breast_Cancer

HER2 over expressing MBC, what is the preferred First line therapy?
Anonymous voting

A patient with HER2-positive MBC was initially treated with a combination of pertuzumab, trastuzumab, and a taxane. After months, her disease progressed. Which of the following treatments is most appropriate as second-line HER2- targeted therapy?
Anonymous voting

Breast Cancer.pdf25.53 MB

#Breast_Cancer
+4
#Breast_Cancer

ุงู…ุณูƒูŠูˆ ู…ุฑุญู„ุฉ ุฎุงู…ุณุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ู…ูˆุงุฏ ุงู„ู†ุธุฑูŠ ุนู„ุงุฌูŠุงุช ุงุฏูุงู†ุณ ุงู‚ุชุตุงุฏูŠุงุช. TDM DDS ุงู„ุจุงูŠูˆุชูƒู†ูˆู„ุฌูŠ ู…/// ู…ู† ู†ู†ุฒู„ ุดูŠ ูŠู†ุถุงู ุน ุงู„ู‚ูˆุงุฆู… ุญุณุจ ูƒู„ ู…ุงุฏุฉ๐Ÿ‘Œ

45-year-old patient with HER2+ breast cancer received neoadjuvant chemotherapy plus trastuzumab and pertuzumab. At surgery, a residual disease was found. Which agent is most appropriate for adjuvant therapy in this condition ?
Anonymous voting

Salma is a 35 years old women presented to gynecologist seeking for strategies for breast cancer prevention because of her positive family history with BRCA 1 and BRCA2 gene test; The best treatment for risk reduction include:
Anonymous voting

Which genetic mutations significantly incrcase the lifetime risk of breast cancer? a- BRCA1 and BRCA2 b- TPS3 and EGFR c- KRAS and NRAS d- ATM and CHEK2 e- BRCA3 and PALB2 ุฏูˆุฑ ุงูˆู„ 2024 ุทุจุนุง ู‡ุงูŠ ุงู„ุงุณุฆู„ุฉ ุชุฎุต ุงูˆู„ ู…ุญุงุถุฑุฉ ู†ุฒู„ุชู‡ุง ุงู„ูƒู… ุงู„ู…ุญุงุถุฑุฉ ุงู„ุฌุงูŠุฉ ุนู„ุงุฌุงุช ุงู„ breast cancer ุณุคุงู„ ุณู‡ู„ ูˆุญุชู‰ ู…ุชู†ุณูˆู† Breast Cancer ู‡ูˆ BR CA #Breast_Cancer

Drug used to prevent Breast cancer. Which drug increased incidence of endometrial cancer a- Exemestane b- anastrozole c- tamoxifen d- raloxifene e- Letrozole ูˆุฒุงุฑูŠ ุฏูˆุฑ ุงูˆู„ 2024 ุงู„ุญู„ ู…ู† ุงู„ุตูˆุฑุฉ ๐Ÿซ† #Breast_Cancer

#Breast_Cancer
#Breast_Cancer

A 41 years old woman with a positive family history of breast cancer. What is the treatment of choice to reduce her risk breast cancer risk?
Anonymous voting

Remember ๐Ÿซ†

A 66 years old woman is suffering from low mineral bone density and strong family history of breast cancer. What would be the best protective agent? #Breast_Cancer
Anonymous voting

Alzheimer Disease.pdf2.67 MB

ุทู„ุงุจ ุงู„ุฎุงู…ุณุฉ ุงู†ุง ุงู† ุดุงุก ุงู„ู„ู‡ ุงูƒู…ู„ ุงู„ูƒุงู†ุณุฑ ูˆุงุจุฏูŠ ุจุงู„ู†ูุณูŠุฉ ู…ู†ุง ู„ุฐุงูƒ ุงู„ูˆู‚ุช ู‡ูˆุงูŠ ุทู„ุงุจ ุชุฑูŠุฏ ู…ู„ุงุฒู… ู…ุฑุชุจุฉ ู„ู„ู†ูุณูŠุฉ ู ุงู† ุดุงุก ุงู„ู„ู‡ ุงุซู†ุงุก ุดุฑุญูŠ ู„ู„ูƒุงู†ุณุฑ ุฑุญ ุชู†ุฒู„ ุจู‚ูŠุฉ ุงู„ู…ูˆุงุถูŠุน ุจุดูƒู„ ู…ู„ุงุฒู… ู…ุฑุชุจุฉ ุชุจุงุนุง